Agilent reports in-line first quarter, says results hurt by US snowstorm

Core Viewpoint - Agilent Technologies reported first-quarter results that were largely in line with Wall Street estimates, with stable demand for its medical tools and lab equipment, although results were negatively impacted by a major U.S. snowstorm [1][2]. Financial Performance - The company reported quarterly revenue of $1.80 billion, slightly below estimates of $1.81 billion [3]. - Revenue from the life sciences and diagnostics segment was $758 million, exceeding estimates of $693 million, while revenue from the CrossLab unit rose 7% to $361 million [3]. - Adjusted profit for the quarter was $1.36 per share, compared to the average analyst estimate of $1.37 [4]. Future Outlook - Agilent raised the top end of its full-year revenue forecast to between $7.3 billion and $7.5 billion, up from the previous expectation of $7.3 billion to $7.4 billion [4]. - Analysts on average were expecting revenue of $7.36 billion for fiscal 2026 [4].